Top Markets
Coin of the day
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Clasificación en acciones #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Precio por acción
$0.04895618
Última sincronización: 2025-03-18
Capitalización bursátil
$5.55M
Cambio (1 día)
-0.04%
Cambio (1 año)
0.00%
País
CA
Comercio WPD Pharmaceuticals Inc. (WBIO)

Categoría

Historial de desdoblamientos de acciones de WPD Pharmaceuticals Inc. (WBIO)
La acción WPD Pharmaceuticals Inc. (símbolo: WBIO) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 16, 2026.
Una acción WBIO comprada antes de Aug 16, 2026 equivaldría hoy a 0 acciones WBIO.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE